Acquired an exclusive worldwide R&D licensing right from Stanford University for the novel isolation method of mouse hematopoietic stem cells. - ネクスジェン株式会社

HOME
News
Acquired an exclusive worldwide R&D licensing right from Stanford University for the novel isolation method of mouse hematopoietic stem cells.

Acquired an exclusive worldwide R&D licensing right from Stanford University for the novel isolation method of mouse hematopoietic stem cells.

Other
2017/06/01

This press release is available in Japanese.

マウス造血幹細胞の新規単離技術に関する全世界の独占的な研究開発ライセンス権を米国スタンフォード大学より取得しました。